Teva Pharmaceutical Completes USD2.3 Billion Offering
Teva Pharmaceutical Industries Ltd. completed a comprehensive USD 2.3 billion senior bond offering accompanied by a coordinated tender offer designed to refinance and optimize its debt capital structure.
Israeli law firm Herzog represented a syndicate of top lenders—including BNP Paribas, BofA Securities, HSBC, and J.P. Morgan—on Teva Pharmaceutical Industries Ltd.’s USD 2.3 billion senior bond issuance and parallel tender offer.
Herzog’s deal team comprised Ron Ben‑Menachem, Mohammad Mawasi, Yaakov Rosenblum, and Shani Balak from its Corporate & Securities Department, alongside Dr. Yuval Navot, Eldad Chamam, Dr. Ehab Farah, and Ronen Avner from its Tax Department.
Meanwhile, Baker & McKenzie served as lead counsel to the underwriting banks, with the cross-border team led by London-based Capital Markets and Leveraged Finance partners David Becker, Rob Mathews, and Ben Bierwirth.
